Search results (15)
« Back to News18 teams in the MRC WIMM receive LEAF Sustainability awards
17 July 2024
Department of Oncology MRC MHU MRC TIDU NDCN RDM
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research laboratories to embed sustainability into their work.
New study shines light on the complex mechanisms of Fetal Growth Restriction in pregnancy
29 July 2022
The paper, published in Nature Communications reveals key genes involved in the common developmental disease.
Seven research groups secure LEAF Sustainability Awards
22 July 2022
Department of Oncology MRC HIU MRC MHU NDCN RDM
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.
Spatial transcriptomics of neurodegeneration in Progressive Multiple Sclerosis (MS)
28 June 2022
In a paper published in Nature Neuroscience, the Fugger Group describe molecular pathways of MS neurodegeneration in unprecedented detail.
Funding awarded for autoimmune disease research
13 May 2022
Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis
16 February 2021
MRC WIMM researchers have revealed a population of immune cells that travel to the brain in patients with multiple sclerosis causing disease. They demonstrate how to trap these cells in the blood, meaning they can be targeted to prevent disease progression.
Angela Vincent honoured for excellence in epilepsy research
17 December 2019
Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.
New research to investigate role of blood-brain barrier
12 February 2019
A new consortium of 27 partners coordinated by our researcher Prof Zameel Cader will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics.
European licence for migraine prevention drug
31 July 2018
MRC WIMM research underpins the first treatment designed specifically for the prevention of migraines
World’s largest autism grant will transform research landscape
18 June 2018
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium that includes the participation of Prof Zameel Cader.
Oxford Centre for Neuroinflammation launched
30 May 2018
The new centre, located at the MRC WIMM, aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.
Prof David Beeson elected Fellow of the Academy of Medical Sciences
10 May 2018
Many congratulations to Prof Beeson for this distinction recognising his exceptional contribution to the study of neuromuscular disorders.
MRC WIMM researchers talk about their research on rare diseases
28 February 2018
Department of Oncology MRC MHU NDCN RDM
To mark rare disease day we asked our researchers to tell us more about the rare conditions that they study, and why their research is important.